-+ 0.00%
-+ 0.00%
-+ 0.00%
Phio Pharmaceuticals to present PH-762 clinical update at Life Sciences Future Conference
Share
Listen to the news
Phio Pharmaceuticals to present PH-762 clinical update at Life Sciences Future Conference
  • Phio Pharmaceuticals will present at the Life Sciences Future 2026 Conference on September 30 to October 1, 2026.
  • Management plans a clinical development update on PH-762 following its completed Phase 1b study in cutaneous squamous cell carcinoma.
  • The talk is scheduled for September 30, 2026 at 10:20 a.m. ET in King of Prussia, Pennsylvania.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Phio Pharmaceuticals Corp. published the original content used to generate this news brief via Newsfile (Ref. ID: 202609230700NEWSFILECNPR____20260923_315517_1) on September 23, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending